Results 181 to 190 of about 1,546,803 (298)

Using prescription medication utilization trends to evaluate health system resilience and inform future emergency preparedness. [PDF]

J Manag Care Spec Pharm
Dardouri M, Wright G, Saseen JJ, Nair KV, Anderson KE.   +4 more
europepmc   +1 more source

Outpatient Mental Health Care Utilization among Frontline Healthcare Workers [PDF]

Chandra L. Bautista, Katelynn A. Bourassa, Namrata N. Vasquez, Alok Madan   +3 more
openalex   +1 more source

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source

Examining the role of social factors in the utilization of preventive cardiovascular clinical services: An analysis using Andersen's behavioral health model. [PDF]

PLoS One
Alamri SS, Abdalrouf AK, Alnouri FM, Suliman AH.   +3 more
europepmc   +1 more source

Insights into substrate binding and utilization by hyaluronan synthase [PDF]

Zachery Stephens, Julia Karasinska, Jochen Zimmer   +2 more
openalex   +1 more source

Integrated genomic and proteomic profiling reveals insights into chemoradiation resistance in cervical cancer

Molecular Oncology, EarlyView.
A comprehensive genomic and proteomic analysis of cervical cancer revealed STK11 and STX3 as a potential biomarkers of chemoradiation resistance. Our study demonstrated EGFR as a therapeutic target, paving the way for precision strategies to overcome treatment failure and the DNA repair pathway as a critical mechanism of resistance.
Janani Sambath, Irene A. George, Srikanth S. Manda, Prasanth Ariyannur, Ekta R. Dhawale, Raja Sekhar Kommu, Rajan Datar, Darshana Patil, Vinita Trivedi, Manisha Singh, Kumar Prabhash, Sewanti Limaye, Richa Chauhan, Prashant Kumar   +13 more
wiley   +1 more source

Blood Component Utilization and Discard Patterns in Telangana, India: A Three-Year Retrospective Study. [PDF]

Cureus
Rai J, Behera NK, Gupta MK, Vemuri P, Kendre BD, Dixit H, Tiwari RV, Agrawal D, Gupta S.   +8 more
europepmc   +1 more source

MON-601 Recent Strides In Diabetes Technology Utilization Among Individuals With Type 1 Diabetes [PDF]

Estelle Everett, Ryan Tiu, Itzel Paola Melgoza, J. C. W. Graham, Giuliana Perini Villanueva, José C. Cruz, Alejandra Rivas Deras, Kelechi Udeze, J Cushing, Billy A. Barrios, José D. Méndez, Evelyn Shaw, Cynthia Santana, Brandon Cobb, Danielle Polan, Alke Guirguis, Nare Ghaltakchyan, David Chukwu, Asmita Manandhar, R.S. Hargrove, Deborah Cheng, Matthew Freeby, Eli Ipp, Tannaz Moin   +23 more
openalex   +1 more source

Resource Utilization

Annals of Surgery, 1985
openaire   +3 more sources

YAP1::TFE3 mediates endothelial‐to‐mesenchymal plasticity in epithelioid hemangioendothelioma

Molecular Oncology, EarlyView.
The YAP1::TFE3 fusion protein drives endothelial‐to‐mesenchymal transition (EndMT) plasticity, resulting in the loss of endothelial characteristics and gain of mesenchymal‐like properties, including resistance to anoikis, increased migratory capacity, and loss of contact growth inhibition in endothelial cells.
Ant Murphy, Samuel Hartzler, Paula A. Vargas Carranza, Shyaman Jayasundara, Madison E. Yates, Nimod D. Janson, Bozhi Liu, Annaleigh Benton, Majid Kazemian, Jason A. Hanna   +9 more
wiley   +1 more source